Latest News & Features
Biotechnology
Lawyers are navigating an “uncertain terrain” when presiding over cases involving biosimilars, a speaker at the 2016 BIO International Convention has said. 8 June 2016
Americas
Gender diversity was the topic of our next video interview where we discovered that the biotechnology industry is an "old boys network". 8 June 2016
Americas
Casey Thampoe, managing IP counsel for biologics and vaccines at Merck & Co, speaks to LSIPR. 8 June 2016
Americas
Hollywood actor Will Smith has praised the power of science and the work of neuropathologist Dr Bennet Omalu during a speech at the 2016 BIO International Convention. 8 June 2016
Africa
The president of Nigeria’s Senate has proposed that people convicted of selling counterfeit drugs and food are jailed for life and fined up to ₦2 million dollars. 7 June 2016
Biotechnology
LSIPR spoke to Dr Claire Skentelbery of the ENABLE project about the need for novel developments and the importance of a solid intellectual property strategy. 7 June 2016
Africa
For something to be innovative it must “add value” and companies must ensure they understand the term in order to succeed, the 2016 BIO International Convention has heard. 7 June 2016
Americas
The 2016 BIO International Convention has heard that drug companies are on a mission to discover new tools to support the development of anti-infectives due to a decrease in the development of new antibiotics. 7 June 2016
Americas
The 2016 BIO International Convention kicked off in style Monday night with an evening of scientific discovery at the Exploratorium. 7 June 2016
Americas
Pharmaceutical company AstraZeneca has agreed a licensing deal with German drug maker Grünenthal centring on gout treatment drug Zurampic. 6 June 2016